X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29279) 29279
Newsletter (115) 115
Magazine Article (84) 84
Book Chapter (72) 72
Book / eBook (31) 31
Conference Proceeding (20) 20
Publication (19) 19
Dissertation (14) 14
Web Resource (12) 12
Book Review (4) 4
Newspaper Article (4) 4
Government Document (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16516) 16516
heparin - pharmacology (13995) 13995
animals (13387) 13387
heparin (9214) 9214
male (7390) 7390
female (5596) 5596
rats (4290) 4290
pharmacology & pharmacy (3886) 3886
anticoagulants - pharmacology (3135) 3135
mice (2877) 2877
biochemistry & molecular biology (2794) 2794
hematology (2726) 2726
anticoagulants (2638) 2638
adult (2633) 2633
middle aged (2509) 2509
cells, cultured (2333) 2333
peripheral vascular disease (2137) 2137
blood coagulation - drug effects (2123) 2123
kinetics (2097) 2097
time factors (2029) 2029
dose-response relationship, drug (1982) 1982
heparin - therapeutic use (1967) 1967
heparin - metabolism (1892) 1892
aged (1812) 1812
anticoagulants - therapeutic use (1808) 1808
molecular-weight heparin (1780) 1780
in vitro techniques (1725) 1725
rabbits (1675) 1675
heparin - administration & dosage (1623) 1623
binding (1437) 1437
glycosaminoglycans (1418) 1418
cattle (1413) 1413
thrombosis (1396) 1396
cell biology (1374) 1374
molecular weight (1310) 1310
heparin - chemistry (1271) 1271
thrombin (1225) 1225
cell line (1220) 1220
expression (1214) 1214
heparin, low-molecular-weight - pharmacology (1172) 1172
molecular sequence data (1171) 1171
protein binding (1145) 1145
unfractionated heparin (1127) 1127
surgery (1106) 1106
research (1095) 1095
activation (1090) 1090
analysis (1082) 1082
anticoagulants - administration & dosage (1079) 1079
dogs (1052) 1052
inhibition (1048) 1048
cardiac & cardiovascular systems (1000) 1000
fibrinolytic agents - pharmacology (981) 981
amino acid sequence (975) 975
partial thromboplastin time (968) 968
anticoagulants - adverse effects (965) 965
proteins (949) 949
heparin - adverse effects (948) 948
binding sites (946) 946
pharmacology (942) 942
cell division - drug effects (926) 926
cells (904) 904
in-vitro (897) 897
venous thromboembolism (875) 875
prevention (868) 868
blood (865) 865
thrombin - antagonists & inhibitors (847) 847
rats, sprague-dawley (834) 834
heparin, low-molecular-weight - therapeutic use (810) 810
protamines - pharmacology (802) 802
research article (802) 802
swine (794) 794
blood coagulation tests (776) 776
disease models, animal (773) 773
therapy (762) 762
enoxaparin (760) 760
immunology (760) 760
platelet aggregation - drug effects (749) 749
medicine, research & experimental (740) 740
plasma (740) 740
angiogenesis (735) 735
coagulation (734) 734
blood platelets - drug effects (731) 731
factor xa inhibitors (716) 716
rats, wistar (715) 715
thromboembolism (713) 713
hydrogen-ion concentration (705) 705
pregnancy (705) 705
risk factors (701) 701
treatment outcome (689) 689
oncology (680) 680
fibrinolytic agents - therapeutic use (679) 679
anticoagulation (677) 677
heparin-binding egf-like growth factor (665) 665
thrombin - metabolism (663) 663
structure-activity relationship (662) 662
physiology (657) 657
recombinant proteins - pharmacology (648) 648
cancer (640) 640
cardiopulmonary bypass (639) 639
deep-vein thrombosis (636) 636
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (27) 27
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Pharmacy (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27368) 27368
German (622) 622
Russian (622) 622
French (430) 430
Japanese (389) 389
Italian (252) 252
Chinese (125) 125
Polish (109) 109
Spanish (102) 102
Czech (65) 65
Portuguese (38) 38
Hungarian (25) 25
Dutch (22) 22
Slovak (12) 12
Romanian (10) 10
Bulgarian (9) 9
Swedish (9) 9
Ukrainian (7) 7
Croatian (5) 5
Danish (5) 5
Korean (5) 5
Norwegian (4) 4
Turkish (4) 4
Hebrew (2) 2
Serbian (2) 2
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology: Cell Physiology, ISSN 0363-6143, 09/2011, Volume 301, Issue 3, pp. C559 - C565
Deliu E, Tica AA, Motoc D, Brailoiu GC, Brailoiu E. Intracellular angiotensin II activates rat myometrium. Am J Physiol Cell Physiol 301: C559-C565, 2011.... 
Calcium imaging | Microinjection | Cytosolic calcium concentration | Endoplasmic reticulum | CYCLIC ADP-RIBOSE | PHYSIOLOGY | ANG-II | LIVER LYSOSOMES | RECEPTOR | microinjection | METABOLIC-CLEARANCE | BLOOD-PRESSURE | UTERINE | CELL BIOLOGY | SIGNAL-TRANSDUCTION | RENAL ENDOSOMES | SMOOTH-MUSCLE-CELLS | calcium imaging | cytosolic calcium concentration | endoplasmic reticulum | Myometrium - drug effects | Type C Phospholipases - metabolism | Brefeldin A - pharmacology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Autophagy - drug effects | Endosomes - metabolism | Angiotensin II Type 2 Receptor Blockers - pharmacology | Macrocyclic Compounds - pharmacology | Saralasin - pharmacology | Endoplasmic Reticulum - drug effects | Estrenes - pharmacology | Myometrium - metabolism | Inositol 1,4,5-Trisphosphate Receptors - antagonists & inhibitors | Ryanodine - pharmacology | Angiotensin II - pharmacology | Pyridines - administration & dosage | Endocytosis - drug effects | Enzyme Inhibitors - pharmacology | Losartan - pharmacology | Saralasin - administration & dosage | Rats | Imidazoles - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptor, Angiotensin, Type 2 - metabolism | Signal Transduction - drug effects | Calcium Signaling - drug effects | Models, Biological | Receptor, Angiotensin, Type 1 - metabolism | Oxazoles - pharmacology | Losartan - administration & dosage | Angiotensin II - administration & dosage | Calcium Signaling - physiology | Endoplasmic Reticulum - metabolism | Imidazoles - administration & dosage | Type C Phospholipases - antagonists & inhibitors | Lysosomes - metabolism | Inositol 1,4,5-Trisphosphate Receptors - metabolism | Pyrrolidinones - pharmacology | Macrolides - pharmacology | NADP - analogs & derivatives | Female | NADP - metabolism | Heparin - pharmacology | Angiotensin II - metabolism | Arsenicals - pharmacology | Cells, Cultured | Sirolimus - pharmacology | Myometrium - cytology | Animals | Egtazic Acid - pharmacology | Uterus - cytology | Signal Transduction - physiology | Pyridines - pharmacology | Carbolines - pharmacology | Myometrium | Cell receptors | Calcium channels | Genetic aspects | Properties | Angiotensin | Receptors and Signal Transduction
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 09/2019, Volume 74, Issue 12, pp. 1618 - 1636
Journal Article
Journal Article
Journal Article
Journal Article
Bone, ISSN 8756-3282, 2012, Volume 50, Issue 4, pp. 974 - 982
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2006, Volume 26, Issue 2, pp. 696 - 707
Natriuretic peptides (NPs) may work as neuromodulators through their associated receptors [NP receptors (NPRs)]. By immunocytochemistry, we showed that NPR-A... 
Brain natriuretic peptide | GABA receptor | Retina | Intracellular calcium | Neuromodulation | Bipolar cells | ATRIAL MYOCYTES | CA2+ RELEASE | brain natriuretic peptide | bipolar cells | DEPENDENT PROTEIN-KINASE | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | neuromodulation | CGMP-ACTIVATED CHANNELS | retina | RYANODINE RECEPTORS | GANGLION-CELLS | NITRIC-OXIDE | intracellular calcium | GUANYLYL CYCLASE RECEPTORS | Calcium-Transporting ATPases - antagonists & inhibitors | Cyclic GMP - pharmacology | Calcium - metabolism | Male | Peptide Fragments - pharmacology | Peptides, Cyclic - pharmacology | Natriuretic Peptide, Brain - pharmacology | Natriuretic Peptide, Brain - physiology | Macrocyclic Compounds | Guanylate Cyclase - drug effects | Cyclic GMP-Dependent Protein Kinases - physiology | Cyclic GMP - analogs & derivatives | Retinal Bipolar Cells - physiology | Guanylate Cyclase - physiology | Receptors, GABA-A - drug effects | Caffeine - pharmacology | Inositol 1,4,5-Trisphosphate Receptors | Indoles - pharmacology | Atrial Natriuretic Factor - pharmacology | Heparin - pharmacology | Ryanodine - pharmacology | Membrane Potentials - drug effects | Calcium Channels | GABA-A Receptor Antagonists | Rats | gamma-Aminobutyric Acid - pharmacology | Imidazoles - pharmacology | Ryanodine Receptor Calcium Release Channel - drug effects | Retinal Bipolar Cells - drug effects | Rats, Sprague-Dawley | Polysaccharides - pharmacology | Receptors, Atrial Natriuretic Factor - physiology | Calmodulin - physiology | Patch-Clamp Techniques | Animals | Ruthenium Red - pharmacology | Calcium Signaling - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Thapsigargin - pharmacology | Natriuretic Peptide, Brain - antagonists & inhibitors | Oxazoles - pharmacology | Protein Kinase Inhibitors - pharmacology | Receptors, Atrial Natriuretic Factor - drug effects | Carbazoles - pharmacology | Receptors, GABA - physiology | Calmodulin - antagonists & inhibitors | Cellular | Molecular
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 4, p. 1264
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2010, Volume 16, Issue 31, pp. 3436 - 3441
Journal Article
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2012, Volume 25, Issue 3, pp. 351 - 360
The standard effective treatment of venous and arterial thromboembolism includes unfractionated and low-molecular weight heparin as well as warfarin, which... 
Hematology, Oncology and Palliative Medicine | new anticoagulants | thromboembolism | factor Xa inhibitors | direct thrombin inhibitors | PREDICTING STROKE | STROKE PREVENTION | DEEP-VEIN THROMBOSIS | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | DABIGATRAN ETEXILATE | MOLECULAR-WEIGHT HEPARIN | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Humans | Thrombin - antagonists & inhibitors | Azetidines - pharmacology | Dabigatran | Thiazoles - therapeutic use | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - pharmacology | Warfarin - therapeutic use | Antithrombins - pharmacology | Rivaroxaban | Clinical Trials, Phase III as Topic | Thromboembolism - drug therapy | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Pyrazoles - pharmacology | Pyridines - therapeutic use | Antithrombins - therapeutic use | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - therapeutic use | Azetidines - therapeutic use | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Pyridines - pharmacology | Pyridones - therapeutic use | Thiazoles - pharmacology | Benzylamines - pharmacology | Benzylamines - therapeutic use | Pyridones - pharmacology
Journal Article